News
Recipharm names 2017 International Environmental Award winner
Recipharm has announced that its 2017 International Environmental Award will be presented to Karen Kidd, Professor in Biology, and Geography & Earth Sciences at McMaster University in Hamilton, Ontario and Jarislowsky Chair in Environment and Health. ...
News
ChargePoint Technology Certified for Supplying Solutions for Hazardous Environments
Powder containment and aseptic transfer valve specialist ChargePoint Technology has obtained the highest level of quality accreditation at its Liverpool, UK facility, to enable future product development for use in hazardous environments. The company now holds...
News
RAPS announces training programme for 510(k) submissions featuring former FDA officials
The Regulatory Affairs Professionals Society (RAPS) continues its support of medical device professionals in Europe with the launch of a workshop focused on 510(k) premarket submissions to the US Food and Drug Administration (FDA). The two-day...
News
Autoclave Manufacturer Priorclave Celebrates 30 Years
A small specialist British engineering company called Priorclave celebrates 30 years in the design, manufacture and world-wide supply of an extensive range of laboratory and research grade autoclaves. The company has achieved considerable export success as...
News
World-Class Speakers Announced for Lonza’s 4th Global Endotoxin Testing Summit
Lonza has announced a panel of top endotoxin experts to present at the 4th Global Endotoxin Testing Summit from 12-14 June 2018, in Annapolis, MD (USA). This year’s event has the theme "Feel the Pulse of...
News
Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3%
Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,105...
News
Cipla and Roche tie-up to sell 2 cancer drugs in India
The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India. This partnership is in line with Cipla and Roche's efforts to improve healthcare and increase access...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read